Impact of B.1.1.7 variant mutations on antibody recognition of linear SARS-CoV-2 epitopes
Haynes, W. A.; Kamath, K.; Lucas, C.; Shon, J.; Iwasaki, A.
10.1101/2021.01.06.20248960 medRxivShow abstract
In 579 COVID patients samples collected between March and July of 2020, we examined the effects of non-synonymous mutations harbored by the circulating B.1.1.7 strain on linear antibody epitope signal for spike glycoprotein and nucleoprotein. At the antigen level, the mutations only substantially reduced signal in 0.5% of the population. Although some epitope mutations reduce measured signal in up to 6% of the population, these are not the dominant epitopes for their antigens. Given dominant epitope patterns observed, our data suggest that the mutations would not result in immune evasion of linear epitopes for a large majority of these COVID patients.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19 93%
- Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals 92%
- Plasmodium infection induces cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein 91%
Similar papers in this journal
- Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography 91%
- SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface 91%
- BA.2 omicron differs immunologically from both BA.1 omicron and pre-omicron variants 91%
Similar papers in this journal
- Influence of HLA class II polymorphism on predicted cellular immunity against SARS-CoV-2 at the population and individual level 93%
- CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains and influenza virus 92%
- Protein-based Immunome Wide Association Studies (PIWAS) for the discovery of significant disease-associated antigens 92%
Similar papers in this journal
- Serological reconstruction of COVID-19 epidemics through analysis of antibody kinetics to SARS-CoV-2 proteins 92%
- Anti-membrane and anti-spike antibodies are long-lasting and together discriminate between past COVID-19 infection and vaccination 92%
- SARS-CoV-2 evolution and patient immunological history shape the breadth and potency of antibody-mediated immunity 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.